Skip to main content
SpringerLink
Log in

Worldwide Challenges and Opportunities of Hybrid Imaging: Perspective from the International Atomic Energy Agency (IAEA)

  • Chapter
  • First Online:
PET-CT and PET-MRI in Neurology

  • 1931 Accesses

Abstract

Imaging in general is currently playing a pivotal role in the clinical management of several serious diseases, either communicable or non-communicable, affecting the central nervous system (CNS). Regarding nuclear medicine imaging specifically, it must be emphasised that dating back as far as the mid-1970s, great advances in our understanding of the physiology of the brain, both in health and in disease, were achieved thanks to the unique capability of radionuclide methods to explore functional aspects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. James ML, Gambhir SS (2012) A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev 92:897–965

    Article  CAS  PubMed  Google Scholar 

  2. Costa DC, Verhoeff NP, Cullum ID et al (1990) In vivo characterisation of 3-iodo-6-methoxybenzamide 123I in humans. Eur J Nucl Med 16:813–816

    Article  CAS  PubMed  Google Scholar 

  3. Abi-Dargham A, Gandelman MS, DeErausquin GA et al (1996) SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT. J Nucl Med 37:1129–1133

    CAS  PubMed  Google Scholar 

  4. Kung HF, Kim HJ, Kung MP, Meegalla SK, Plössl K, Lee HK (1996) Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med 23:1527–1530

    Article  CAS  PubMed  Google Scholar 

  5. Britz-Cunningham SH, Adelstein SJ (2003) Molecular targeting with radionuclides: state of the science. J Nucl Med 44:1945–1961

    CAS  PubMed  Google Scholar 

  6. Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M (2007) Nuclear imaging in cancer theranostics. Q J Nucl Med Mol Imaging 51:152–163

    PubMed  Google Scholar 

  7. Srivastava SC (2012) Paving the way to personalized medicine: production of some promising theragnostic radionuclides at Brookhaven National Laboratory. Semin Nucl Med 42:151–163

    Article  PubMed  Google Scholar 

  8. Fink JR, Muzi M, Peck M, Krohn KA (2015) Multimodality brain tumor imaging: MR imaging, PET, and PET/MR imaging. J Nucl Med 56:1554–1561

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Seibyl J, Zubal IG, Jennings D, Marek K, Doraiswamy PM (2011) Molecular PET imaging in multicenter Alzheimer’s therapeutic trials: current trends and implementation strategies. Expert Rev Neurother 11:1783–1793

    Article  CAS  PubMed  Google Scholar 

  10. Jiménez Bonilla JF, Carril Carril JM (2013) Molecular neuroimaging in degenerative dementias. Rev Esp Med Nucl Imagen Mol 32:301–309

    PubMed  Google Scholar 

  11. Heiss WD (2014) PET imaging in ischemic cerebrovascular disease: current status and future directions. Neurosci Bull 30:713–732

    Article  CAS  PubMed  Google Scholar 

  12. Peng S, Eidelberg D, Ma Y (2014) Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease. Neurosci Bull 30:823–837

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Politis M (2014) Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol 10:708–722

    Article  PubMed  Google Scholar 

  14. Ba F, Martin WR (2015) Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice. Parkinsonism Relat Disord 21:87–94

    Article  PubMed  Google Scholar 

  15. Miller DB, O’Callaghan JP (2015) Biomarkers of Parkinson’s disease: present and future. Metabolism 64(3 Suppl 1):S40–S46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hirao K, Pontone GM, Smith GS (2015) Molecular imaging of neuropsychiatric symptoms in Alzheimer’s and Parkinson’s disease. Neurosci Biobehav Rev 49:157–170

    Article  PubMed  PubMed Central  Google Scholar 

  17. Weingarten CP, Sundman MH, Hickey P, Chen NK (2015) Neuroimaging of Parkinson’s disease: expanding views. Neurosci Biobehav Rev 59:16–52

    Article  PubMed  Google Scholar 

  18. Hricak H, Choi BI, Scott AM, Sugimura K et al (2010) Global trends in hybrid imaging 1. Radiology 257:498–506

    Article  PubMed  Google Scholar 

  19. Segall G (2012) SNM and global cooperation. J Nucl Med 53:19N

    PubMed  Google Scholar 

  20. Pringsheim T, Jette N, Frolkis A, Steeves TD (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1583–1590

    Article  PubMed  Google Scholar 

  21. Disorders N (2006) Public health challenges. World Health Organization, Geneva

    Google Scholar 

  22. Kalaria RN, Maestre GE, Arizaga R et al (2008) Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 7:812–826

    Article  PubMed  PubMed Central  Google Scholar 

  23. World Health Organization. Dementia – A public health priority. Geneva: World Health Organization; 2012.

    Google Scholar 

  24. Park JA, Kim JY, Lee YJ et al (2012) Gadolinium complex of 125I/127I-RGD-DOTA conjugate as a tumor-targeting SPECT/MR bimodal imaging probe. ACS Med Chem Lett 4:216–219

    Article  PubMed  PubMed Central  Google Scholar 

  25. Mariani G, Bruselli L, Kuwert T et al (2010) A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging 37:1959–1985

    Article  PubMed  Google Scholar 

  26. Buck AK, Nekolla S, Ziegler S et al (2008) SPECT/CT. J Nucl Med 49:1305–1319

    Article  PubMed  Google Scholar 

  27. Warwick JM, Rubow S, du Toit M, Beetge E, Carey P, Dupont P (2011) The role of CT-based attenuation correction and collimator blurring correction in striatal SPECT quantification. Int J Mol Imaging 2011:195037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hayashi M, Deguchi J, Utsunomiya K et al (2005) Comparison of methods of attenuation and scatter correction in brain perfusion SPECT. J Nucl Med Technol 33:224–229

    PubMed  Google Scholar 

  29. Ciarmiello A, Giovacchini G, Guidotti C et al (2013) Weighted registration of 123I-FP-CIT SPECT images improves accuracy of binding potential estimates in pathologically low striatal uptake. J Cell Physiol 228:2086–2094

    Article  CAS  PubMed  Google Scholar 

  30. Schillaci O, Danieli R, Manni C, Simonetti G (2004) Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun 25:705–710

    Article  PubMed  Google Scholar 

  31. Berti V, Pupi A, Mosconi L (2011) PET/CT in diagnosis of movement disorders. Ann N Y Acad Sci 1228:93–108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Calabria F, Chiaravalloti A, Di Pietro B, Grasso C, Schillaci O (2012) Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT. Nucl Med Commun 33:563–570

    Article  PubMed  Google Scholar 

  33. Segtnan EA, Hess S, Grupe P, Høilund-Carlsen PF (2015) 18F-fluorodeoxyglucose PET/computed tomography for primary brain tumors. PET Clin 10:59–73

    Article  PubMed  Google Scholar 

  34. Shivamurthy VK, Tahari AK, Marcus C, Subramaniam RM (2015) Brain FDG PET and the diagnosis of dementia. AJR Am J Roentgenol 204:W76–W85

    Article  PubMed  Google Scholar 

  35. Wray R, Solnes L, Mena E, Meoded A, Subramaniam RM (2015) 18F-Flourodeoxy-glucose PET/computed tomography in brain tumors: value to patient management and survival outcomes. PET Clin 10:423–430

    Article  PubMed  Google Scholar 

  36. Heiss WD (2009) The potential of PET/MR for brain imaging. Eur J Nucl Med Mol Imaging 36(Suppl 1):S105–S112

    Article  PubMed  Google Scholar 

  37. Bisdas S, Nägele T, Schlemmer HP et al (2010) Switching on the lights for real-time multimodality tumor neuroimaging: the integrated positron-emission tomography/MR imaging system. AJNR Am J Neuroradiol 31:610–614

    Article  CAS  PubMed  Google Scholar 

  38. Garibotto V, Heinzer S, Vulliemoz S et al (2013) Clinical applications of hybrid PET/MRI in neuroimaging. Clin Nucl Med 38:e13–e18

    Article  PubMed  Google Scholar 

  39. Von Schulthess GK, Kuhn FP, Kaufmann P, Veit-Haibach P (2013) Clinical positron emission tomography/magnetic resonance imaging applications. Semin Nucl Med 43:3–10

    Article  Google Scholar 

  40. Burgos N, Cardoso MJ, Thielemans K et al (2014) Attenuation correction synthesis for hybrid PET-MR scanners: application to brain studies. IEEE Trans Med Imaging 33:2332–2341

    Article  PubMed  Google Scholar 

  41. Barthel H, Schroeter ML, Hoffmann KT, Sabri O (2015) PET/MR in dementia and other neurodegenerative diseases. Semin Nucl Med 45:224–233

    Article  PubMed  Google Scholar 

  42. Kashyap R, Dondi M, Paez D, Mariani G (2013) Hybrid imaging worldwide – Challenges and opportunities for the developing world: a report of a technical meeting organized by the IAEA. Semin Nucl Med 43:208–223

    Article  PubMed  Google Scholar 

  43. Paez D, Orellana P, Gutierrez C, Ramirez R, Mut F, Torres L (2015) Current status of nuclear medicine practice in Latin America and the Caribbean. J Nucl Med 56:1629–1634

    Article  PubMed  Google Scholar 

  44. Olssen M, Codd JA, O’Neill A-M (2004) Education policy: globalization, citizenship and democracy. Sage Publications, London

    Google Scholar 

  45. Osman MM, Cohade C, Fishman EK et al (2005) Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies: frequency in 250 patients. J Nucl Med 46:1352–1355

    PubMed  Google Scholar 

  46. Bruzzi JF, Truong MT, Marom EM et al (2006) Incidental findings on integrated PET/CT that do not accumulate 18F-FDG. AJR Am J Roentgenol 187:1116–1123

    Article  PubMed  Google Scholar 

  47. Goetze S, Pannu HK, Wahl RL (2006) Clinically significant abnormal findings on the “nondiagnostic” CT portion of low-amperage-CT attenuation-corrected myocardial perfusion SPECT/CT studies. J Nucl Med 47:1312–1318

    PubMed  Google Scholar 

  48. Muzaffar R, Kudva G, Nguyen NC et al (2011) Incidental diagnosis of thrombus within an aneurysm on 18F-FDG PET/CT: frequency in 926 patients. J Nucl Med 52:1408–1411

    Article  PubMed  Google Scholar 

  49. Fathala A, Aljefri A, Alsugair A et al (2011) Coronary artery calcification detected by PET/CT scan as a marker of myocardial ischemia/coronary artery disease. Nucl Med Commun 32:273–278

    Article  PubMed  Google Scholar 

  50. Tootell A, Vinjamuri S, Elias M, Hogg P (2012) Clinical evaluation of the computed tomography attenuation correction map for myocardial perfusion imaging: the potential for incidental pathology detection. Nucl Med Commun 33:1122–1126

    Article  PubMed  Google Scholar 

  51. Zandieh S, Schütz M, Bernt R, Zwerina J, Haller J (2013) An incidentally found inflamed uterine myoma causing low abdominal pain, using Tc-99m-tektrotyd single photon emission computed tomography-CT hybrid imaging. Korean J Radiol 14:841–844

    Article  PubMed  PubMed Central  Google Scholar 

  52. Wuest W, Lell M, May MS, Saake M, Kuwert T, Uder M, Linke R (2015) Thoracic non-osseous lesions in cancer patients detected in low-dose CT images acquired as part of skeletal SPECT/CT examinations. Nuklearmedizin 54:173–177

    Article  CAS  PubMed  Google Scholar 

  53. International Atomic Energy Agency (IAEA) – Statute of the IAEA. Available online at http://www.iaea.org/About/about_statute.html. 1956. Last accessed online 10 May 2015.

  54. Dondi M, Kashyap R, Paez D, Pascual T, Zaknun J, Mut Bastos F, Pynda Y (2011) Trends in nuclear medicine in developing countries. J Nucl Med 52(Suppl 2):16S–23S

    Article  PubMed  Google Scholar 

  55. Dondi M (2013) Guest editorial: IAEA approach to meet nuclear medicine needs of the emerging world. Semin Nucl Med 43:159–160

    Article  PubMed  Google Scholar 

  56. Pascual TN, Dondi M, Paez D, Kashyap R, Nunez-Miller R (2013) IAEA programs in empowering the nuclear medicine profession through online educational resources. Semin Nucl Med 43:161–166

    Article  PubMed  Google Scholar 

  57. Casas-Zamora JA, Kashyap R (2013) The IAEA technical cooperation programme and nuclear medicine in the developing world: objectives, trends, and contributions. Semin Nucl Med 43:172–180

    Article  PubMed  Google Scholar 

  58. Meghzifene A, Sgouros G (2013) IAEA support to medical physics in nuclear medicine. Semin Nucl Med 43:181–187

    Article  PubMed  Google Scholar 

  59. Duatti A, Bhonsle U (2013) Strengthening radiopharmacy practice in IAEA Member States. Semin Nucl Med 43:188–194

    Article  PubMed  Google Scholar 

  60. Patterson HE, Nunez M, Philotheou GM, Hutton BF (2013) Meeting the challenges of global nuclear medicine technologist training in the 21st century: the IAEA Distance Assisted Training (DAT) program. Semin Nucl Med 43:195–201

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, International Atomic Energy Agency (IAEA), Wagramer Strasse 5, Vienna, Austria

    Diana Paez, T. N. B. Pascual & R. Kashyap

  2. Regional Center of Nuclear Medicine, University of Pisa Medical School, Via Roma 67, Pisa, 56126, Italy

    Giuliano Mariani

Authors
  1. Diana Paez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuliano Mariani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. N. B. Pascual
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Kashyap
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Diana Paez .

Editor information

Editors and Affiliations

  1. S. Andrea Hospital, Department of Nuclear Medicine, La Spezia, Italy

    Andrea Ciarmiello

  2. Department of Nuclear Medicine, Second University of Naples, Napoli, Italy

    Luigi Mansi

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Paez, D., Mariani, G., Pascual, T.N.B., Kashyap, R. (2016). Worldwide Challenges and Opportunities of Hybrid Imaging: Perspective from the International Atomic Energy Agency (IAEA). In: Ciarmiello, A., Mansi, L. (eds) PET-CT and PET-MRI in Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-31614-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31614-7_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31612-3

  • Online ISBN: 978-3-319-31614-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation